Danaher Balance Sheet Health
Financial Health criteria checks 5/6
Danaher has a total shareholder equity of $50.9B and total debt of $16.5B, which brings its debt-to-equity ratio to 32.4%. Its total assets and total liabilities are $79.1B and $28.3B respectively. Danaher's EBIT is $5.1B making its interest coverage ratio 23. It has cash and short-term investments of $2.0B.
Key information
32.4%
Debt to equity ratio
US$16.48b
Debt
| Interest coverage ratio | 23x |
| Cash | US$1.99b |
| Equity | US$50.86b |
| Total liabilities | US$28.26b |
| Total assets | US$79.12b |
Recent financial health updates
Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly
Dec 08
Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Is Danaher (NYSE:DHR) A Risky Investment?
May 21Recent updates
Danaher: Q1 Beat Fails To Trigger Guidance Upgrade
May 02Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations
Mar 31Estimating The Fair Value Of Danaher Corporation (NYSE:DHR)
Mar 26Danaher: Near 5-Year Low Is A Great Entry Point
Mar 22Danaher Corporation Just Missed EPS By 5.5%: Here's What Analysts Think Will Happen Next
Feb 24Danaher: Self-Inflicted Pessimism?
Feb 17Investors Appear Satisfied With Danaher Corporation's (NYSE:DHR) Prospects
Jan 27Danaher Corporation: Question Mark Behind The Moat And Probably Overvalued
Jan 15At US$238, Is Danaher Corporation (NYSE:DHR) Worth Looking At Closely?
Jan 10Danaher: A Wide-Moat Gem I Cannot Buy Enough Of
Jan 06Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)
Dec 26Danaher: A Resilient And Solid Company With Growth Potential
Dec 10Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly
Dec 08Understanding Danaher's Cautiousness
Oct 25Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27
Strategic Spin-off and Innovations To Deliver Durable Growth and Stronger Financial Health
Feb 19Danaher's focus on life sciences and diagnostics through a spin-off and strategic acquisitions aims to secure durable growth in future revenue and earnings.Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Financial Position Analysis
Short Term Liabilities: DHR's short term assets ($9.5B) exceed its short term liabilities ($6.6B).
Long Term Liabilities: DHR's short term assets ($9.5B) do not cover its long term liabilities ($21.6B).
Debt to Equity History and Analysis
Debt Level: DHR's net debt to equity ratio (28.5%) is considered satisfactory.
Reducing Debt: DHR's debt to equity ratio has reduced from 82.4% to 32.4% over the past 5 years.
Debt Coverage: DHR's debt is well covered by operating cash flow (37.9%).
Interest Coverage: DHR's interest payments on its debt are well covered by EBIT (23x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 23:36 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2025/03/28 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Danaher Corporation is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Catherine Ramsey Schulte | Baird |
| Robert Cornell | Barclays |